Biosimilars [Design Issues]

posted by drgunasakaran1  – 2012-02-06 14:57 (4844 d 21:09 ago) – Posting: # 8059
Views: 6,429

❝ […] kindly explain me can i enroll healthy subjects for biosimilars BA/BE study ?


Dear Mr.Vasu,

You can enroll healthy volunteers in the Pharmacokinetic studies required for Biosimilars like Interferon alpha See section 5 Clinical Studies (Page 5 of 7).

Efficacy and safety studies of Biosimilars will be done in patient population.

Kindly go through EMA's Product Specific Biosimilar Guidances.



Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
107 visitors (0 registered, 107 guests [including 66 identified bots]).
Forum time: 13:07 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5